This inventor holds 2 USPTO granted patents. Top assignees: British Columbia Cancer Agency Branch, The University of British Columbia. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Vancouver, CA (2018)
- Richmond, CA (2021)
Company Filing History:
2 out of 66 
1 out of 963 
Years Active: 2018-2021
Title: Innovations of Jinhe Pan in Cancer Research
Introduction
Jinhe Pan is a notable inventor based in Richmond, CA, who has made significant contributions to the field of cancer research. He holds 2 patents that focus on novel compounds and methods for targeting specific cancer markers. His work is particularly relevant in the context of prostate cancer and other disorders.
Latest Patents
One of Jinhe Pan's latest patents involves the development of 18/19F-labelled compounds that target the prostate-specific membrane antigen (PSMA). This disclosure relates to innovative compounds that comprise a zwitterionic trifluoroborate prosthetic group, which are designed to target PSMA in prostate cancer. The compounds have a specific formula where each R1 is an anionic group, L is a linker, and R2B-F3 is a pyridinium group substituted with BFor methyl BF, or an azole group substituted with methyl BF3. Additionally, methods and uses for imaging and treating PSMA-expressing cancers are disclosed in this patent.
Another significant patent focuses on compositions that target the bradykinin receptor B1 for medical imaging of cancer and other disorders. This patent describes bradykinin B1 receptor (B1R) targeting peptides and compounds that are radiolabelled with radioisotopes suitable for imaging and/or radiotherapy. The radiolabelled peptides and compounds have utility in imaging tissues that express or overexpress B1R, as well as in treating diseases or conditions where B1R is expressed or overexpressed, including cancer.
Career Highlights
Jinhe Pan has worked with prestigious institutions such as the British Columbia Cancer Agency and The University of British Columbia. His experience in these organizations has contributed to his expertise in cancer research and innovation.
Collaborations
Jinhe Pan has collaborated with Kuo-shyan Lin, further enhancing his research capabilities and contributions to the field.
Conclusion
Jinhe Pan's innovative work in cancer research, particularly through his patents targeting PSMA and B1R, showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer and highlight the importance of targeted therapies in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile